Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirogabalin vs Pregabalin in Diabetic Peripheral Neuropathic Pain
NCT07451431Phase 4Recruiting
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Oct 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mirogabalin in diabetic polyneuropathy (DPN) (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Neuropathic Pain Scale at 8 weeks. Started Oct 2025; status: recruiting.
02
Drugs
mirogabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT07451431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07451431.